Economic Consequences of the Adaption of the 21 Gene Reverse Transcriptase-Polymerase Chain Reaction RT-PCR Assay from The Greek Third Payer Perspective.

Kikilias, N; Siskou, O; Kaitelidou, D; Galanis, P; Tsoulos, N; Vafeiadis, J; Liaropoulos, L

Kikilias, N; Siskou, O; Kaitelidou, D; Galanis, P; Tsoulos, N; Vafeiadis, J; Liaropoulos, L.

Afiliação

Kikilias N; National Organization for Health Care Services Provision -EOPYY, Marousi, Greece.
Siskou O; Center for Health Services Management and Evaluation, National and Kapodistrian University of Athens, Athens, Greece.
Kaitelidou D; National and Kapodistrian University of Athens, Athens, Greece.
Galanis P; National and Kapodistrian University of Athens, Athens, Greece.
Tsoulos N; GENEKOR, Gerakas, Greece.
Vafeiadis J; National Organization for Health Care Services Provision -EOPYY, Marousi, Greece.
Liaropoulos L; National and Kapodistrian University of Athens, Athens, Greece.

Value Health ; 17(7): A630-1, 2014 Nov.

Article em En | MEDLINE | ID: mdl-27202238

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google